Home LiteratureArticle Details
PMID: 16437143 Published · ppublish English Letter Research Support, Non-U.S. Gov't

Immunotherapy of B-cell malignancies with genetically engineered human CD8+ natural killer T cells.

Leukemia ·Vol. 20 ·No. 4 ·2006-04-00 ·Pages 729-32

Pieper M, Scheffold C, Duwe S, Rossig C, Bisping G, Stelljes M, Tedder TF, Jurgens H, Berdel WE, Kienast J

Abstract

暂无摘要

MeSH Terms
Antigens, CD20/immunology CD8-Positive T-Lymphocytes/immunology Genetic Engineering Humans Immunotherapy/methods Killer Cells, Natural/immunology Lymphoma, B-Cell/immunology,therapy
Chemicals
Antigens, CD20
Authors & Affiliations
10 authors, click to expand affiliations / ORCID
Pieper M
Scheffold C
Duwe S
Rossig C
Bisping G
Stelljes M
Tedder T F
Jurgens H
Berdel W E
Kienast J
Article Info
Journal
Leukemia
Abbr.
Leukemia
ISSN
0887-6924
DOI
10.1038/sj.leu.2404114
Published
2006-04-00
Pages
729-32
Language
English
Region
England
NLM ID
8704895
Subset
IM
External Links
PubMed source DOI: 10.1038/sj.leu.2404114 View journal details
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com

Copyright © 2026.Genelibs Jinan Honghui Biotechnology Co., Ltd. 鲁ICP备20007159号-2